Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: The PLATINO study

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 7, 2008, Pages 709-712

  Menezes, A M B ^a   Perez Padilla, R ^b   Hallal, P C ^a   Jardim, J R ^c   Muino A ^d   Lopez, M V ^d   Valdivia, G ^e   Pertuze, J ^e   Montes De Oca, M ^f   Telamo C ^f  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^f UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

COPD; Latin America; Respiratory function tests; Smoking; Spirometry

Indexed keywords

COAL;

AIRWAY OBSTRUCTION; ARTICLE; BRAZIL; CHILE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DUST; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEXICO; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SOUTH AND CENTRAL AMERICA; SPIROMETRY; URUGUAY; VENEZUELA;

ADULT; COST OF ILLNESS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 47149101486     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lopez A D, Mathers C D, Ezzati M, Jamison D T, Murray C J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
2. Monteiro C A, Cavalcante T M, Moura E C, Claro R M, Szwarcwald C L. Population-based evidence for strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ 2007; 85: 527-534.
3. Menezes A M, Victora C G, Perez-Padilla R. The Platino project: methodology of a multicentre prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 2004; 4: 15.
4. Menezes A M, Perez-Padilla R, Jardim J R, et al. Chronic-obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
5. Pérez-Padilla R, Vázquez-García J C, Márquez M N, et al. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2006; 51: 1167-1171.
6. Celli B R, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD documents and resource: Guent, 2005. http://www.ibge.gov.br/home/estatistica/ populacao/censo2000/tabelabrasil111.shtm Accessed January 2008.
8. Talamo C, Oca M M, Halbert R, et al. Diagnostic labeling of COPD in five Latin American cities. Chest 2007; 131: 60-67.
9. Lopez M V, Muiño A, Pérez-Padilla R, et al. Tratamiento de la EPOC en 5 ciudades de América Latina: estudio PLATINO. Arch Bronconeumol 2008; 44: 58-64. [Spanish]
10. Buist A S, McBurnie M A, Vollmer W M, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
11. Caballero A, Arturo Torres-Duque C, Jaramillo C, et al. Prevalence of chronic obstructive pulmonary disease in five Colombian cities situated at low, medium and high altitude (PREPOCOL Study). Chest 2008; 133: 333-334.